WINTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
WINDTREE THERAPEUTICS INC /DE/
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 19, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $26.68K
- P/E (TTM)
- –
- Dividend yield
- –
Windtree Therapeutics statistics
Financials through Sep 30, 2025, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Market Cap | $33.71K | $164.85M |
| Enterprise Value | -$170.29K | $87.06M |
Income (trailing twelve months)
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$33.50M | -$21.44M |
| Pretax Income | -$43.50M | -$14.45M |
| Net Income | -$39.99M | -$22.46M |
| EBITDA | -$33.50M | -$16.91M |
Returns
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Return on Assets (ROA) | -172.3% | -41.0% |
Balance sheet
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $204.00K | $62.42M |
| Net Cash (Debt) | $204.00K | $15.68M |
| Net Cash Per Share | $0.01 | $0.66 |
| Equity (Book Value) | -$11.61M | $48.79M |
| Book Value Per Share | -$0.34 | $1.36 |
| Tangible Book Value | -$11.61M | $23.06M |
| Working Capital | -$14.70M | $75.77M |
Financial position
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 0.33 | 3.30 |
| Quick Ratio | 0.01 | 2.39 |
| Interest Coverage | -68.64 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$15.12M | -$12.35M |
Efficiency
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$2.86M | -$703.34K |
| Employee Count | 14 | 74 |
Dividends and yields
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -118646.0% | -22.7% |
Shares
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 33,708,800 | 58,179,650 |
| Shares Change (QoQ) | 263.7% | 0.54% |
| Float | 33,708,800 | 49,173,100 |
| Shares Held by Insiders | 0.00% | 11.6% |
Taxes
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Income Tax | -$3.51M | $91.50K |
Scores
| Measure | Windtree Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -85.92 | -0.24 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Windtree Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.